MiMedx Group Inc. (MDXG)
MiMedx Statistics
Share Statistics
MiMedx has 147.37M shares outstanding. The number of shares has increased by -0.16% in one year.
| Shares Outstanding | 147.37M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | 0.29% |
| Owned by Institutions (%) | 68.64% |
| Shares Floating | 115.91M |
| Failed to Deliver (FTD) Shares | 16 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 4.09M, so 2.78% of the outstanding shares have been sold short.
| Short Interest | 4.09M |
| Short % of Shares Out | 2.78% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 6.78 |
Valuation Ratios
The PE ratio is 33.33 and the forward PE ratio is 18.81. MiMedx's PEG ratio is -0.84.
| PE Ratio | 33.33 |
| Forward PE | 18.81 |
| PS Ratio | 4.05 |
| Forward PS | 1.8 |
| PB Ratio | 7.32 |
| P/FCF Ratio | 21.92 |
| PEG Ratio | -0.84 |
Enterprise Valuation
MiMedx has an Enterprise Value (EV) of 1.31B.
| EV / Sales | 3.76 |
| EV / EBITDA | 20.37 |
| EV / EBIT | 19.8 |
| EV / FCF | 20.31 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.21 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | 58.51 |
Financial Efficiency
Return on Equity is 21.97% and Return on Invested Capital is 19.67%.
| Return on Equity | 21.97% |
| Return on Assets | 16.07% |
| Return on Invested Capital | 19.67% |
| Revenue Per Employee | $416.82K |
| Profits Per Employee | $50.68K |
| Employee Count | 837 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 2.52 |
Taxes
| Income Tax | 15.3M |
| Effective Tax Rate | 26.7% |
Stock Price Statistics
The stock price has increased by 8.67% in the last 52 weeks. The beta is 1.75, so MiMedx's price volatility has been higher than the market average.
| Beta | 1.75 |
| 52-Week Price Change | 8.67% |
| 50-Day Moving Average | 7.85 |
| 200-Day Moving Average | 7.54 |
| Relative Strength Index (RSI) | 33.19 |
| Average Volume (20 Days) | 570.02K |
Income Statement
In the last 12 months, MiMedx had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.
| Revenue | 348.88M |
| Gross Profit | 288.81M |
| Operating Income | 58.87M |
| Net Income | 42.42M |
| EBITDA | 64.34M |
| EBIT | 58.3M |
| Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 104.42M in cash and 1M in debt, giving a net cash position of 103.42M.
| Cash & Cash Equivalents | 104.42M |
| Total Debt | 1M |
| Net Cash | 103.42M |
| Retained Earnings | -91.26M |
| Total Assets | 263.92M |
| Working Capital | 146.29M |
Cash Flow
In the last 12 months, operating cash flow was 66.2M and capital expenditures -1.68M, giving a free cash flow of 64.52M.
| Operating Cash Flow | 66.2M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | 64.52M |
| FCF Per Share | 0.44 |
Margins
Gross margin is 82.78%, with operating and profit margins of 16.87% and 12.16%.
| Gross Margin | 82.78% |
| Operating Margin | 16.87% |
| Pretax Margin | 16.42% |
| Profit Margin | 12.16% |
| EBITDA Margin | 18.44% |
| EBIT Margin | 16.87% |
| FCF Margin | 18.49% |
Dividends & Yields
MDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3% |
| FCF Yield | 4.56% |
Analyst Forecast
The average price target for MDXG is $12, which is 77.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 77.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Apr 2, 2008. It was a backward split with a ratio of 647:2000.
| Last Split Date | Apr 2, 2008 |
| Split Type | backward |
| Split Ratio | 647:2000 |
Scores
| Altman Z-Score | 11.12 |
| Piotroski F-Score | 6 |